Intellia Therapeutics, Inc.
Company Information
Industry
In Vitro & In Vivo Diagnostic Substances
SIC Code
2835
Entity Type
operating
SEC Category
Large accelerated filer
State of Incorporation
DE
Business Address
40 ERIE STREET, CAMBRIDGE, MA, 02139
Mailing Address
40 ERIE STREET, CAMBRIDGE, MA, 02139
Phone
857-285-6200
Fiscal Year End
1231
EIN
364785571
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 8-K Current report of material events | March 2, 2026 | View on SEC |
| 424B5 Prospectus supplement | March 2, 2026 | View on SEC |
Material Events
8-K
Strategy Change
March 2, 2026
High Impact
- FDA lifted clinical hold on MAGNITUDE trial for nexiguran ziclumeran (nex-z), Intellia's lead drug candidate.
- Expanded 'at-the-market' (ATM) stock offering program by $400 million, increasing total potential capital to $1 billion.
Insider Trading
SELL
8 insiders
13 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2835)
Aspira Women's Health Inc.
AWHL
In Vitro & In Vivo Diagnostic Substances
VOLITIONRX LTD
VNRX
In Vitro & In Vivo Diagnostic Substances
IMMUCELL CORP /DE/
ICCC
In Vitro & In Vivo Diagnostic Substances
Insight Molecular Diagnostics Inc.
IMDX
In Vitro & In Vivo Diagnostic Substances
ACHIEVE LIFE SCIENCES, INC.
ACHV
In Vitro & In Vivo Diagnostic Substances
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.